TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 58 filers reported holding TCR2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $987,504 | +35.2% | 658,336 | -10.0% | 0.04% | +43.3% |
| Q4 2022 | $730,501 | -62.9% | 731,379 | -33.2% | 0.03% | -60.5% |
| Q3 2022 | $1,970,000 | -37.9% | 1,094,645 | 0.0% | 0.08% | -37.2% |
| Q2 2022 | $3,174,000 | +5.1% | 1,094,645 | 0.0% | 0.12% | +28.7% |
| Q1 2022 | $3,021,000 | -51.8% | 1,094,645 | -18.7% | 0.09% | -34.3% |
| Q4 2021 | $6,273,000 | -80.7% | 1,346,058 | -64.7% | 0.14% | -74.7% |
| Q3 2021 | $32,480,000 | -38.8% | 3,816,709 | +18.0% | 0.57% | -28.0% |
| Q2 2021 | $53,100,000 | -33.4% | 3,235,809 | -10.4% | 0.79% | -30.0% |
| Q1 2021 | $79,726,000 | -9.0% | 3,610,788 | +27.5% | 1.12% | +5.8% |
| Q4 2020 | $87,621,000 | +54.4% | 2,832,888 | +1.4% | 1.06% | +1.8% |
| Q3 2020 | $56,760,000 | +109.3% | 2,793,288 | +58.2% | 1.04% | +108.0% |
| Q2 2020 | $27,113,000 | +98.2% | 1,765,188 | -0.1% | 0.50% | +30.8% |
| Q1 2020 | $13,679,000 | -46.8% | 1,767,288 | -1.8% | 0.38% | -37.7% |
| Q4 2019 | $25,692,000 | -4.5% | 1,799,188 | +0.5% | 0.62% | -31.7% |
| Q3 2019 | $26,908,000 | +4.5% | 1,790,288 | -0.5% | 0.90% | +23.5% |
| Q2 2019 | $25,747,000 | -10.2% | 1,799,216 | -0.4% | 0.73% | -13.1% |
| Q1 2019 | $28,686,000 | – | 1,807,256 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |